相关实验视频
Updated: Jan 16, 2026

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
44.4K
青少年高血压中的内皮功能障碍:诊断挑战和早期心血管风险
Vladimir Micieta1, Michaela Cehakova2, Ingrid Tonhajzerova1
1Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Journal of cardiovascular development and disease
|September 26, 2025
概括
青少年的高血压导致早期血管损伤和内皮功能障碍 (ED),增加心血管风险. 早期发现和干预,如运动,饮食和药物可以逆转ED,并保持年轻人的血管健康.
科学领域:
- 心血管研究研究心血管研究
- 儿科健康 儿科健康
- 血管生物学 血管生物学
背景情况:
- 青少年高血压与早期血管损伤有关,特别是内皮功能障碍 (ED).
- 内皮功能障碍意味着年轻人心血管风险增加.
- 青春期的荷尔蒙变化加剧了血管变化.
研究的目的:
- 审查最近 (2020-2025) 关于高血压青少年ED机制和检测的研究结果.
- 探索ED的可逆性及其对心血管风险管理的影响.
- 强调在年轻人中早期发现ED的重要性.
主要方法:
- 关于高血压年轻人内皮功能障碍的最新科学文献 (2020-2025) 的综合.
- 对ED评估的非侵入性诊断工具的分析 (例如,流媒体扩张,外围动脉度计).
- 审查干预策略,包括改变生活方式和药物治疗.
主要成果:
- 减少氧化的生物可用性,氧化应激,炎症和荷尔蒙变化有助于ED和血管重塑.
- 无症状的高血压青少年表现出可测量的ED,动脉硬和心脏变化.
- 年轻人的内皮功能障碍通过干预是可逆的.
结论:
- 在高血压青少年中早期发现ED对于准确的风险分层至关重要.
- 运动,饮食和药物 (ACE抑制剂,ARBs) 等干预措施可以改善内皮功能.
- 在年轻人中迅速治疗ED,为保持长期血管健康和预防心血管疾病提供了一个窗口.
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
471
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hypertension II: Pathophysiology
795
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Hypertension I: Introduction
743
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
743
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Coronary Artery Disease I: Introduction
882
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
882
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
540
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540

